You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
萊美藥業(300006.SZ):公司資產公開掛牌轉讓未徵集到意向受讓方
格隆匯 10-13 17:34

格隆匯10月13日丨萊美藥業(300006.SZ)公佈,公司於2020年3月22日通過重慶聯合產權交易所集團首次公開掛牌轉讓公司直接或間接持有的湖南康源製藥有限公司(以下簡稱“湖南康源”)100%股權、公司直接持有的四川禾正製藥有限責任公司(以下簡稱“四川禾正”)100%股權(含其全資子公司成都禾正生物科技有限公司、四川萊禾醫藥科技有限公司)、重慶萊美健康產業有限公司(以下簡稱“萊美健康”)60%股權和重慶萊美金鼠中藥飲片有限公司(以下簡稱“萊美金鼠”)70%股權(以下簡稱“標的股權”),截止2020年10月12日,標的股權公開掛牌期滿,本輪掛牌轉讓未徵集到意向受讓方。

公司結合市場情況將繼續在重慶產權交易網公開掛牌轉讓標的股權,掛牌條件與首次掛牌條件保持一致,本次掛牌公告期為2020年10月14日至2020年11月10日。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account